Roger Y. Tsien
Corporate Officer/Principal chez University of California, Berkeley
Profil
Roger Y.
Tsien is the founder of Senomyx, Inc. (founded in 1998), Alume Biosciences, Inc. (founded in 2017), and Avelas Biosciences, Inc. (founded in 2008).
At Avelas Biosciences, he was also a Research Collaborator.
Currently, he holds the title of Professor-Pharmacology, Chemistry & Biochemistry at the University of California, Berkeley.
In the past, he was a Member of the National Academy of Sciences.
Postes actifs de Roger Y. Tsien
| Sociétés | Poste | Début |
|---|---|---|
| University of California, Berkeley | Corporate Officer/Principal | - |
Anciens postes connus de Roger Y. Tsien
| Sociétés | Poste | Fin |
|---|---|---|
Alume Biosciences, Inc.
 Alume Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Alume Biosciences, Inc. operates as an biotechnology company. It develops nerve- targeted pharmaceuticals for surgical and therapeutic use. The company was founded by Quyen Nguyen, Brett Berman, Chrysa Mineo, Mike Whitney, and Roger Tsien in 2017 and is headquartered in San Diego, CA. | Fondateur | - |
| SENOMYX INC. | Fondateur | - |
Avelas Biosciences, Inc.
 Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Fondateur | - |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Commercial Services |
Senomyx, Inc.
 Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Senomyx, Inc. engages in the development and commercialization of flavor ingredients for the packaged food, beverage, and ingredient supply industries. It develops high intensity sweeteners, savory flavors, bitter taste blockers, and cooling agents. The company was founded by Paul A. Grayson, Lubert Stryer, Yon Chien Tsien, Denis Baylor, Harold McGee, and Charles Zuker on September 16, 1998 and is headquartered in San Diego, CA. | Consumer Non-Durables |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Health Services |
Alume Biosciences, Inc.
Alume Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Alume Biosciences, Inc. operates as an biotechnology company. It develops nerve- targeted pharmaceuticals for surgical and therapeutic use. The company was founded by Quyen Nguyen, Brett Berman, Chrysa Mineo, Mike Whitney, and Roger Tsien in 2017 and is headquartered in San Diego, CA. | Commercial Services |
